FIRST-ENGOT-Ov44 (ENGOT/GCIG/Tesaro)

Trial Description: 
A Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Ovarian
Trial Status: 
Recruiting
Contact person: